Luye Pharma Ag

Acino Ag

Luye Pharma Switzerland Ag

Björn Schurad

Thomas Beckert

Gabriel Wauer

Ludwig Grader

Heike Prinz

Kristina Linder

Holger Piotrowski

Manuela Aigle

Heike Hausner

Britta Langer

Marieke Gosau

Britta SCHRÖDER

Julia Fahrmeir

Peter Antropius

Nicola Dabdoub

Ingo Teutsch

Ulrike Kolling

Christian Benda

Sonja Schmitt

Nouha Salman

Lorena Schneider

The present invention relates to a transdermal therapeutic system for administration of an active ingredient and a process for the preparation thereof. The transdermal therapeutic system comprises an overtape with two adhesive layers.

Transdermal therapeutic system with an overtape comprising two adhesive layers

The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, said system being suitable for an application period of at least three days, comprising the layers arranged in the following order with respect to each other:

Transdermal therapeutic system for administering an active substance

The present invention relates to a transdermal therapeutic system for administering an active substance through the skin, comprising:

Transdermal therapeutic system for administering rivastigmine or derivatives thereof

The invention relates to a transdermal therapeutic system () comprising an active ingredient depot () that contains at least one active ingredient, comprising an application face which is designed for applying on a skin and which is adhesive on at least some parts of the surface, and comprising a protective film () which covers the application face and which comprises a first protective film part () and a second protective film part (). The first protective film part () differs from the second protective film part () in terms of physical properties.

Application aid

Growing community of inventors

Munich, Germany

Björn Schurad